ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L04AC" (108)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Basiliximab (L04AC02) 2 products WHO-DDD DrugBank.ca 
  IP  Simulect 20 mg k.A.Dry substance: Basiliximabum 20 mgNovartis Pharma
Schweiz AG		BG
  IP  Simulect 20 mgampoule(s)2050.242310.10k.A.Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung: Basiliximabum 20 mgNovartis Pharma
Schweiz AG		BG
Ustekinumab (L04AC05) 35 products WHO-DDD DrugBank.ca 
L IPCI Stelara 45 mg 1401.061540.1510 %Injection solution: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGB / SL / SOG
L IPCI Stelara 45 mgsyringe(s)1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGB / SL / SOG
L IPCI Stelara 90 mgsyringe(s)1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlJanssen-Cilag AGB / SL / SOG
L IP  Stelara 130 mg 1401.061540.1510 %Concentrate for infusion: Ustekinumabum 130mg / 26mlJanssen-Cilag AGB / SL / SOG
L IPCI Stelara 90 mg/1.0 ml 1401.061540.1510 %Injektionslösung im Fertigpen: Ustekinumabum 90 mg/mlJanssen-Cilag AGB / SL / SOG
L IPCI Stelara 45 mg/0.5 ml 1401.061540.1510 %Injektionslösung im Fertigpen: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGB / SL / SOG
L IPCI Wezenla 45 mg/0.5 ml 1401.061540.1510 %Injection solution: Ustekinumabum 45mg / 0.5mlAmgen Switzerland AGB / SL / SGG
L IPCI Imuldosa 45 mg/0,5 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlAccord Healthcare AGB / SL / SGG
L IPCI Imuldosa 90 mg/1,0 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlAccord Healthcare AGB / SL / SGG
L IPCI Pyzchiva 45 mg/0.5 mL 1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlSamsung Bioepis CH
GmbH		B / SL / SGG
L IPCI Pyzchiva 90 mg/1 mL 1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlSamsung Bioepis CH
GmbH		B / SL / SGG
L IPCI Ustekinumab Spirig HC 45 mg / 0.5 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlSpirig HealthCare AGB / SL / SGG
L IPCI Ustekinumab Spirig HC 90 mg / 1 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlSpirig HealthCare AGB / SL / SGG
L IPCI Wezenla 45 mg/0.5 ml 1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlAmgen Switzerland AGB / SL / SGG
L IPCI Wezenla 90 mg/1 ml 1401.061540.1510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlAmgen Switzerland AGB / SL / SGG
L    Yesintek 45 mg / 0.5 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlMedius AGB / SL / SGG
L    Yesintek 90 mg / 1.0 ml 1120.851252.6510 %Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlMedius AGB / SL / SGG
L IP  Imuldosa 130 mg / 26 ml 1120.851252.6510 %Concentrate for infusion: Ustekinumabum 130mg / 26mlAccord Healthcare AGB / SL / SGG
L IP  Pyzchiva 130 mg 1401.061540.1510 %Concentrate for infusion: Ustekinumabum 130mg / 26mlSamsung Bioepis CH
GmbH		B / SL / SGG
L IP  Steqeyma 130mg / 26mL 1401.061540.1510 %Concentrate for infusion: Ustekinumabum 130mg / 26mliQone Healthcare
Switzerland SA		B / SL / SGG
L IP  Wezenla 130 mg/26 ml 1401.061540.1510 %Concentrate for infusion: Ustekinumabum 130mg / 26mlAmgen Switzerland AGB / SL / SGG
L    Yesintek 130 mg / 26 ml 1120.851252.6510 %Concentrate for infusion: Ustekinumabum 130mg / 26mlMedius AGB / SL / SGG
L IPCI Steqeyma 45mg / 0.5mL 1401.061540.1510 %solution injectable en seringue préremplie: Ustekinumabum 45mg / 0.5mliQone Healthcare
Switzerland SA		B / SL / SGG
L IPCI Steqeyma 90mg / 1.0mL 1401.061540.1510 %solution injectable en seringue préremplie: Ustekinumabum 90 mg/mliQone Healthcare
Switzerland SA		B / SL / SGG
  IP  Ustekinumab Spirig HC® 1120.851252.6510 %Spirig HealthCare AGB / SGG
    CMStreltima 45 mg k.A.Injection solution: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGBG
    CMStreltima 45 mg k.A.Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGBG
    CMStreltima 90 mg k.A.Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlJanssen-Cilag AGBG
    CMStreltima 130 mg k.A.Concentrate for infusion: Ustekinumabum 130mg / 26mlJanssen-Cilag AGBG
    CMStreltima 45 mg/0.5 ml k.A.Injektionslösung im Fertigpen: Ustekinumabum 45mg / 0.5mlJanssen-Cilag AGBG
    CMStreltima 90 mg/1.0 ml k.A.Injektionslösung im Fertigpen: Ustekinumabum 90 mg/mlJanssen-Cilag AGBG
  IP  Ustekinumab Spirig HC 130
mg/26 ml		 10 %Spirig HealthCare AGB / SL / SGG
     Otulfi 45 mg/0.5 ml k.A.Injection solution in prefilled syringe: Ustekinumabum 45mg / 0.5mlFresenius Kabi
(Schweiz) AG		BG
     Otulfi 90 mg/1 ml k.A.Injection solution in prefilled syringe: Ustekinumabum 90 mg/mlFresenius Kabi
(Schweiz) AG		BG
     Otulfi 130 mg k.A.Concentrate for infusion: Ustekinumabum 130mg / 26mlFresenius Kabi
(Schweiz) AG		BG
Tocilizumab (L04AC07) 16 products WHO-DDD DrugBank.ca 
LSIPIPCI Actemra 200 mg/10 mlDurchstechflasche(n)231.93267.3510 %Concentrate for infusion: Tocilizumabum 200mg / 10mlRoche Pharma
(Schweiz) AG		A / SL / SOG
LSIPIPCI Actemra 400 mg/20 mlDurchstechflasche(n)463.85518.3010 %Concentrate for infusion: Tocilizumabum 400mg / 20mlRoche Pharma
(Schweiz) AG		A / SL / SOG
LSIPIPCI Actemra 80 mg/4 mlDurchstechflasche(n)92.77116.8010 %Concentrate for infusion: Tocilizumabum 80mg / 4mlRoche Pharma
(Schweiz) AG		A / SL / SOG
L IPCI Actemra 162 mg/0.9 ml4962.961042.9510 %Injektionslösung in einem Fertigpen zur subkutanen Anwendung: Tocilizumabum 162mg / 0.9mlRoche Pharma
(Schweiz) AG		A / SL / SOG
L IPCI Actemra 162 mg/0.9 ml4 Fertigspritze(n)962.961042.9510 %Injektionslösung zur subkutanen Anwendung: Tocilizumabum 162mg / 0.9mlRoche Pharma
(Schweiz) AG		A / SL / SOG
L IPCI Avtozma 162mg/0.9 ml4625.92697.1510 %iQone Healthcare
Switzerland SA		A / SL / SGG
L IPCI Avtozma 162 mg/0.9 ml4625.92697.1510 %iQone Healthcare
Switzerland SA		A / SL / SGG
L IP  Avtozma 80 mg/ 4ml 84.34108.1510 %Concentrate for infusion: Tocilizumabum 80mg / 10mliQone Healthcare
Switzerland SA		A / SL / SGG
L IP  Avtozma 200 mg/10 ml 210.85245.7510 %Concentrate for infusion: Tocilizumabum 200mg / 10mliQone Healthcare
Switzerland SA		A / SL / SGG
L IP  Avtozma 400 mg/20 ml 421.71475.0510 %Concentrate for infusion: Tocilizumabum 400mg / 20mliQone Healthcare
Switzerland SA		A / SL / SGG
L IP  Tocilizumab Spirig HC 80
mg/4 ml		 84.34108.1510 %Concentrate for infusion: Tocilizumabum 80mg / 4mlSpirig HealthCare AGA / SL / SGG
L IP  Tocilizumab Spirig HC 200
mg/10 ml		 210.85245.7510 %Concentrate for infusion: Tocilizumabum 200mg / 10mlSpirig HealthCare AGA / SL / SGG
L IP  Tocilizumab Spirig HC 400
mg/20 ml		 421.71475.0510 %Concentrate for infusion: Tocilizumabum 400mg / 20mlSpirig HealthCare AGA / SL / SGG
  IP  Tocilizumab Spirig HC 80
mg/4 ml		4k.A.Concentrate for infusion: Tocilizumabum 80mg / 4mlSpirig HealthCare AGAG
  IP  Tocilizumab Spirig HC 200
mg/10 ml		4k.A.Concentrate for infusion: Tocilizumabum 200mg / 10mlSpirig HealthCare AGAG
  IP  Tocilizumab Spirig HC 400
mg/20 ml		4k.A.Concentrate for infusion: Tocilizumabum 400mg / 20mlSpirig HealthCare AGAG
Canakinumab (L04AC08) 2 products WHO-DDD DrugBank.ca 
L IPCIPPIlaris 10377.3310954.9510 %Injection solution: Canakinumabum 150 mg/mlNovartis Pharma
Schweiz AG		A / SLG
L IPCI Ilaris 150 mg/ml 10377.3310954.9510 %Injektionslösung in einem Fertigpen: Canakinumabum 150 mg/mlNovartis Pharma
Schweiz AG		A / SLG
Secukinumab (L04AC10) 8 products WHO-DDD DrugBank.ca 
L IPCIPPCosentyx 150 mg / 1 mlFertigspritze(n)538.86602.4510 %Injection solution in prefilled syringe: Secukinumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SLG
L IPCIPPCosentyx 300 mg / 2 ml 1074.571185.1010 %Injection solution in prefilled syringe: Secukinumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
L IPCIPPCosentyx 75 mg / 0.5 ml 269.43309.4510 %Injection solution in prefilled syringe: Secukinumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		B / SLG
L IPCIPPCosentyx 150 mg / 1 ml2 Fertigspritze(n)1074.571185.1010 %Injection solution in prefilled syringe: Secukinumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SLG
L IP PPCosentyx 150 mgDurchstechflasche(n)538.86602.4510 %Dry substance: Secukinumabum 150 mgNovartis Pharma
Schweiz AG		B / SLG
L IPCI Cosentyx UnoReady 300 mg / 2 ml 1074.571185.1010 %Injektionslösung im Fertigpen: Secukinumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
L IPCIPPCosentyx SensoReady 150 mg / 1 ml 538.86602.4510 %Injektionslösung in Fertigpen: Secukinumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SLG
L IPCIPPCosentyx SensoReady 150 mg / 1 ml21074.571185.1010 %Injektionslösung in Fertigpen: Secukinumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SLG
Siltuximab (L04AC11) 2 products WHO-DDD DrugBank.ca 
  IP  Sylvant 100 mgDurchstechflasche(n)k.A.Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Siltuximabum 110 mgMedius AGAG
  IP  Sylvant 400 mgDurchstechflasche(n)k.A.Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Siltuximabum 420 mgMedius AGAG
Ixekizumab (L04AC13) 3 products WHO-DDD DrugBank.ca 
L IPCIPPTaltz 80 mg 918.671015.5010 %Injection solution in prefilled syringe: Ixekizumabum 80 mgEli Lilly (Suisse) SAB / SLG
L IPCIPPTaltz 80 mg 918.671015.5010 %solution injectable en seringue préremplie: Ixekizumabum 80 mg/mlEli Lilly (Suisse) SAB / SLG
  IPCIPPTaltz 40 mg k.A.solution injectable en seringue préremplie: Ixekizumabum 40mg / 0.5mlEli Lilly (Suisse) SABG
Sarilumab (L04AC14) 4 products WHO-DDD  
L IPCI Kevzara 150 mg/1.14 ml2959.371059.8010 %solution pour injection en seringue préremplie: Sarilumabum 150mg / 1.14mlSanofi-Aventis
(Suisse) SA		B / SLG
L IPCI Kevzara 200 mg/1.14 ml2959.371059.8010 %solution pour injection en seringue préremplie: Sarilumabum 200mg / 1.14mlSanofi-Aventis
(Suisse) SA		B / SLG
L IPCI Kevzara 150 mg/1.14 ml2959.371059.8010 %solution pour injection en stylo prérempli: Sarilumabum 150mg / 1.14mlSanofi-Aventis
(Suisse) SA		B / SLG
L IPCI Kevzara 200 mg/1.14 ml2959.371059.8010 %solution pour injection en stylo prérempli: Sarilumabum 200mg / 1.14mlSanofi-Aventis
(Suisse) SA		B / SLG
Guselkumab (L04AC16) 9 products WHO-DDD  
L IPCI Tremfya 100 mg/1 ml 1906.812090.2010 %Injection solution in prefilled syringe: Guselkumabum 100 mg/mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 200 mg/2 ml 1906.812090.2010 %Injection solution in prefilled syringe: Guselkumabum 200mg / 2mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 200 mg/2 ml23813.624163.9510 %Injection solution in prefilled syringe: Guselkumabum 200mg / 2mlJanssen-Cilag AGB / SLG
L IP  Tremfya 200 mg/20 ml 3813.624163.9510 %Concentrate for infusion: Guselkumabum 200mg / 20mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 200 mg/2 ml 1906.812090.2010 %Injektionslösung im Fertigpen: Guselkumabum 200mg / 2mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 200 mg/2 ml23813.624163.9510 %Injektionslösung im Fertigpen: Guselkumabum 200mg / 2mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 100 mg/1 ml 1906.812090.2010 %Injektionslösung in einem Fertigpen: Guselkumabum 100 mg/mlJanssen-Cilag AGB / SLG
L IPCI Tremfya 100 mg/1 ml 1906.812090.2010 %Injektionslösung in einem Fertigpen: Guselkumabum 100 mg/mlJanssen-Cilag AGB / SLG
  IP  Tremfya 45 mg/0.45 ml k.A.Injektionslösung im Fertigpen: Guselkumabum 45mg / 0.45mlJanssen-Cilag AGBG
Tildrakizumab (L04AC17) 4 products WHO-DDD  
L IPCI Ilumetri 200 mg/2 ml 2962.663238.5010 %Injection solution: Tildrakizumabum 200mg / 2mlAlmirall AGB / SLG
L IPCI Ilumetri 100 mg/1 ml 2962.663238.5010 %Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGB / SLG
L IPCI Ilumetri, 100 mg/1 ml 2962.663238.5010 %Injektionslösung im Fertigpen: Tildrakizumabum 100 mg/mlAlmirall AGB / SLG
  IPCI Ilumetri 100 mg/1 ml2k.A.Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGBG
Risankizumab (L04AC18) 7 products WHO-DDD  
L IP  Skyrizi 600 mg/10 ml 2139.562343.3010 %Concentrate for infusion: Risankizumabum 600mg / 10mlAbbVie AGB / SLG
L IP  Skyrizi 600 mg/10 ml22139.562343.3010 %Concentrate for infusion: Risankizumabum 600mg / 10mlAbbVie AGB / SLG
L IPCI Skyrizi 150mg 2877.973146.4010 %Injektionslösung im Fertigpen: Risankizumabum 150 mg/mlAbbVie AGB / SLG
L IPCI Skyrizi 360 mg 2139.562343.3010 %Injektionslösung in einer Patrone für ein Dosiergerät: Risankizumabum 360mg / 2.4mlAbbVie AGB / SLG
L IPCI Skyrizi 180 mg 2139.562343.3010 %Injektionslösung in einer Patrone für ein Dosiergerät: Risankizumabum 180mg / 1.2mlAbbVie AGB / SLG
L IPCI Skyrizi 150 mg 2877.973146.4010 %lnjektionslösung in einer Fertigspritze: Risankizumabum 150 mg/mlAbbVie AGB / SLG
  IPCI Skyrizi 75 mg23293.763622.10k.A.lnjektionslösung in einer Fertigspritze: Risankizumabum 75mg / 0.83mlAbbVie AGBG
Satralizumab (L04AC19) 1 products WHO-DDD  
L IPCI Enspryng 120 mg 6682.567164.1010 %Injektionslösung zur subkutanen Anwendung: Satralizumabum 120 mg/mlRoche Pharma
(Schweiz) AG		A / SLG
Bimekizumab (L04AC21) 6 products WHO-DDD  
L IPCI Bimzelx 160 mg 915.921012.5510 %Injection solution in prefilled syringe: Bimekizumabum 160 mg/mlUCB-Pharma SAB / SLG
L IPCI Bimzelx 320 mg 1831.842008.6510 %Injection solution in prefilled syringe: Bimekizumabum 320mg / 2mlUCB-Pharma SAB / SLG
L IPCI Bimzelx 160 mg21831.842008.6510 %Injection solution in prefilled syringe: Bimekizumabum 160 mg/mlUCB-Pharma SAB / SLG
L IPCI Bimzelx 160 mg 915.921012.5510 %solution injectable en seringue préremplie: Bimekizumabum 160 mg/mlUCB-Pharma SAB / SLG
L IPCI Bimzelx 320 mg 1831.842008.6510 %solution injectable en seringue préremplie: Bimekizumabum 320mg / 2mlUCB-Pharma SAB / SLG
L IPCI Bimzelx 160 mg21831.842008.6510 %solution injectable en seringue préremplie: Bimekizumabum 160 mg/mlUCB-Pharma SAB / SLG
Spesolimab (L04AC22) 2 products WHO-DDD  
L IP  Spevigo 450 mg/7,5 ml (60
mg/ml)		215635.5116349.8510 %Concentrate for infusion: Spesolimabum 450mg / 7.5mlLEO Pharmaceutical
Products Sarath Ltd.		A / SLG
  IPCI Spevigo 150 mg/1ml2k.A.LEO Pharmaceutical
Products Sarath Ltd.		BG
Mirikizumab (L04AC24) 7 products WHO-DDD  
L IP  Omvoh 200 mg 1126.231241.2510 %Injection solution in prefilled syringe: Mirikizumabum 200mg / 2mlEli Lilly (Suisse) SAB / SLG
L IPCI Omvoh 100 mg21126.231241.2510 %Injection solution in prefilled syringe: Mirikizumabum 100 mg/mlEli Lilly (Suisse) SAB / SLG
L IPCI Omvoh 100 mg + 200 mg1 +1126.231241.2510 %Injection solution in prefilled syringe: Mirikizumabum 200mg / 2ml
Injection solution in prefilled syringe: Mirikizumabum 100 mg/ml		Eli Lilly (Suisse) SAB / SLG
L IP  Omvoh 300 mg 1126.231241.2510 %Concentrate for infusion: Mirikizumabum 300mg / 15mlEli Lilly (Suisse) SAB / SLG
  IP  Omvoh 200 mg k.A.solution injectable en seringue préremplie: Mirikizumabum 200mg / 2mlEli Lilly (Suisse) SABG
  IP  Omvoh 100 mg2k.A.solution injectable en seringue préremplie: Mirikizumabum 100 mg/mlEli Lilly (Suisse) SABG
  IP  Omvoh 100 mg + 200 mg1 +k.A.solution injectable en seringue préremplie: Mirikizumabum 200mg / 2ml
solution injectable en seringue préremplie: Mirikizumabum 100 mg/ml		Eli Lilly (Suisse) SABG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home